Evidence map›Paper›PMID 33370213›Full record

Observational studyJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2021

Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.

Giovanni William Oliverio, Rosaria Spinella, Elisa Imelde Postorino, Leandro Inferrera, Emanuela Aragona, Pasquale Aragona

Abstract readObservational Study
In one paragraph

Observational study in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. AnAntibiotics (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Recent progress of nanomedicine in managing dry eye disease.Advances in ophthalmology practice and research
    Review
  15. Povidone Iodine 0.66% to FightCase reports in ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giovanni William OliverioDepartment of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Rosaria SpinellaDepartment of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Elisa Imelde PostorinoDepartment of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Leandro InferreraDepartment of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Emanuela AragonaDepartment of Ophthalmology, Vita-Salute University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Pasquale AragonaDepartment of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overDrug ToleranceDry Eye SyndromesEmulsionsFemaleHumansMaleMiddle AgedNanoparticlesOphthalmic SolutionsPovidone-IodineProspective StudiesYoung AdultEmulsionsOphthalmic SolutionsPovidone-Iodineantibiotic resistanceantisepticdry eye diseasemicrobiotaocular surfacepovidone–iodine

Identifiers

PMID33370213
PMCPMC7984652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.